TNFSF15

Chr 9

TNF superfamily member 15

The protein functions as a TNF ligand family cytokine that binds to receptors TNFRSF25 and TNFRSF6B, activates NF-kappaB signaling, and regulates endothelial cell apoptosis and angiogenesis inhibition. Based on the low pLI score (0.003) and high LOEUF score (0.95), this gene appears highly tolerant to loss-of-function mutations, and no established Mendelian diseases have been definitively linked to TNFSF15 mutations in the pediatric population. The predicted dominant-negative mechanism suggests potential pathogenicity through protein interference rather than haploinsufficiency.

OMIMResearchSummary from RefSeq, UniProt, Mechanism
MultiplemechanismLOEUF 0.95
Clinical SummaryTNFSF15
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
Some data sources returned errors (1)

ncbi: Error: NCBI fetch failed: 429 https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.95LOEUF
pLI 0.003
Z-score 1.70
OE 0.48 (0.260.95)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.54Z-score
OE missense 0.87 (0.751.01)
121 obs / 138.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.48 (0.260.95)
00.351.4
Missense OE0.87 (0.751.01)
00.61.4
Synonymous OE0.86
01.21.6
LoF obs/exp: 6 / 12.5Missense obs/exp: 121 / 138.9Syn Z: 0.79
DN
0.7230th %ile
GOF
0.6540th %ile
LOF
0.2484th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

TNFSF15 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →